🇺🇸 FDA
Pipeline program

Givinostat 75 mg capsules, Givinostat 100 mg capsules, Givinostat 50 mg capsules

DSC/11/2357/44

Phase 2 small_molecule active

Quick answer

Givinostat 75 mg capsules, Givinostat 100 mg capsules, Givinostat 50 mg capsules for Chronic myeloproliferative neoplasm is a Phase 2 program (small_molecule) at Italfarmaco S.p.A. with 1 ClinicalTrials.gov record(s).

Program details

Company
Italfarmaco S.p.A.
Indication
Chronic myeloproliferative neoplasm
Phase
Phase 2
Modality
small_molecule
Status
active

Clinical trials